MSB 2.51% 97.0¢ mesoblast limited

Ann: Trading Halt, page-74

  1. 7,911 Posts.
    lightbulb Created with Sketch. 627
    With the FDA ……I do think you are pretty much correct especially with Dr Marks
    Wether or not they were led up the garden path is open to discussion
    But with hindsight we (meaning shareholders) were not informed about the BLA process with respect to the fact that they were only ever interested in testing the homogeneity of the product and never going to pass the marketing application…..but now we know
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.